A detailed history of New York State Common Retirement Fund transactions in Maxcyte, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 9,437 shares of MXCT stock, worth $38,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,437
Previous 23,637 60.08%
Holding current value
$38,786
Previous $93,000 60.22%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.68 - $5.06 $52,256 - $71,852
-14,200 Reduced 60.08%
9,437 $37,000
Q2 2024

Jul 31, 2024

BUY
$3.63 - $5.0 $14 - $20
4 Added 0.02%
23,637 $93,000
Q1 2024

May 07, 2024

SELL
$3.94 - $5.38 $122 - $166
-31 Reduced 0.13%
23,633 $99,000
Q4 2023

Feb 01, 2024

SELL
$2.6 - $5.24 $452 - $911
-174 Reduced 0.73%
23,664 $111,000
Q3 2023

Nov 07, 2023

SELL
$3.02 - $5.1 $140,109 - $236,609
-46,394 Reduced 66.06%
23,838 $74,000
Q2 2023

Aug 07, 2023

SELL
$3.69 - $5.35 $74,386 - $107,850
-20,159 Reduced 22.3%
70,232 $322,000
Q1 2023

May 02, 2023

SELL
$4.03 - $5.89 $60,450 - $88,350
-15,000 Reduced 14.23%
90,391 $447,000
Q4 2022

Jan 30, 2023

BUY
$4.92 - $7.4 $19 - $29
4 Added 0.0%
105,391 $575,000
Q3 2022

Nov 08, 2022

BUY
$4.52 - $6.51 $61,707 - $88,874
13,652 Added 14.88%
105,387 $685,000
Q2 2022

Aug 04, 2022

BUY
$3.59 - $6.81 $84,246 - $159,810
23,467 Added 34.37%
91,735 $434,000
Q1 2022

May 05, 2022

SELL
$5.26 - $10.84 $129,217 - $266,295
-24,566 Reduced 26.46%
68,268 $477,000
Q4 2021

Feb 02, 2022

BUY
$8.87 - $12.94 $453,558 - $661,673
51,134 Added 122.62%
92,834 $946,000
Q3 2021

Nov 02, 2021

BUY
$12.21 - $17.2 $509,157 - $717,240
41,700 New
41,700 $509,000

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $418M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.